Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52,265,866
-
Total 13F shares
-
31,922,535
-
Share change
-
+481,567
-
Total reported value
-
$165,661,708
-
Price per share
-
$5.19
-
Number of holders
-
88
-
Value change
-
+$2,319,069
-
Number of buys
-
37
-
Number of sells
-
58
Institutional Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q2 2018
As of 30 Jun 2018,
ENZO BIOCHEM INC - Common Stock (ENZB) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,922,535 shares.
The largest 10 holders included
Evermore Global Advisors, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, MANUFACTURERS LIFE INSURANCE COMPANY, THE, GILDER GAGNON HOWE & CO LLC, STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.